THE SIRTUIN 6 ATTENUATES MYOCARDIAL INJURY AND DYSFUNCTION BY REGULATING ADAM17/ACE2 PATHWAY IN HYPERTENSIVE RATS

被引：0
|
作者：
Cheng, Yu-Wen [1 ]
Xu, Ying-Le [1 ]
Zhang, Zhen-Zhou [1 ]
Wang, Juan [2 ,3 ]
Liu, Xiao-Yan [2 ,3 ]
Li, Jing [2 ,3 ]
Fan, Yi-Fan [2 ,3 ]
Yang, Mei [2 ,3 ]
Yang, Xin-Chun [2 ,3 ]
Zhong, Jiu-Chang [2 ,3 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med China, Hypertens Ruijin Hosp, Shanghai Inst, Shanghai, Peoples R China
[2] Capital Med Univ China, Heart Ctr, Beijing Chaoyang Hosp, Beijing, Peoples R China
[3] Capital Med Univ China, Beijing Key Lab Hypertens, Beijing Chaoyang Hosp, Beijing, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2018年 / 36卷
关键词：
SIRT6; fibrosi s; myocardial injury; ACE2; hypertension;
D O I：
10.1097/01.hjh.0000548274.70902.b3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
A12686
引用
收藏
页码：E70 / E70
页数：1
相关论文
共 50 条
  • [41] The sirtuin 6 prevents angiotensin II-mediated myocardial fibrosis and injury by targeting AMPK-ACE2 signaling
    Zhang, Zhen-Zhou
    Cheng, Yu-Wen
    Jin, Hai-Yan
    Chang, Qing
    Shang, Qian-Hui
    Xu, Ying-Le
    Chen, Lin-Xi
    Xu, Ran
    Song, Bei
    Zhong, Jiu-Chang
    ONCOTARGET, 2017, 8 (42) : 72302 - 72314
  • [42] Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL-6/STAT3 signaling pathway
    Shi, Wei
    Men, Lintong
    Pi, Xiu
    Jiang, Tao
    Peng, Dewei
    Huo, Shengqi
    Luo, Pengcheng
    Wang, Moran
    Guo, Junyi
    Jiang, Yue
    Peng, Lulu
    Lin, Li
    Li, Sheng
    Lv, Jiagao
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 59 (06)
  • [43] Activation of NRF2/FPN1 pathway attenuates myocardial ischemia–reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis
    Hao Tian
    Yonghong Xiong
    Yi Zhang
    Yan Leng
    Jie Tao
    Lu Li
    Zhen Qiu
    Zhongyuan Xia
    Cell Stress and Chaperones, 2022, 27 : 149 - 164
  • [44] ADAM17, ACE2, TMPRSS2 and TNFAIP2-comparative immunohistochemical landscape in lungs of fatal cases of SarsCov-19 and AH1N1 influenza infection
    Neagu, R.
    Zurac, S.
    Balea, M.
    Nichita, L.
    Stanciu, L.
    Niculae, S.
    Cibotariu, A.
    Marinoiu, D. M.
    Bordea, A.
    Ionescu, R.
    Dumitru, C.
    Vilaia, A.
    Popp, C.
    VIRCHOWS ARCHIV, 2024, 485 : S446 - S446
  • [45] Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis
    Tian, Hao
    Xiong, Yonghong
    Zhang, Yi
    Leng, Yan
    Tao, Jie
    Li, Lu
    Qiu, Zhen
    Xia, Zhongyuan
    CELL STRESS & CHAPERONES, 2022, 27 (02): : 149 - 164
  • [46] Chemical renal denervation-induced upregulation of the ACE2/Ang (1-7)/Mas axis attenuates blood pressure elevation in spontaneously hypertensive rats
    Han, Wenzheng
    Wang, Ming
    Zhai, Xinrong
    Gan, Qian
    Guan, Shaofeng
    Qu, Xinkai
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2020, 42 (07) : 661 - 668
  • [47] Resveratrol attenuates myocardial injury in septic rats via inhibition of the JAK2/STAT3 signaling pathway
    Ji, Zhiyong
    Li, Yubo
    Sun, Guoqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1724 - 1731
  • [48] Glycyrrhizic Acid Alleviates Lipopolysaccharide (LPS)-Induced Acute Lung Injury by Regulating Angiotensin-Converting Enzyme-2 (ACE2) and Caveolin-1 Signaling Pathway
    Chen, Yangye
    Qu, Lihua
    Li, Yi
    Chen, Chao
    He, Wei
    Shen, Li
    Zhang, Ran
    INFLAMMATION, 2022, 45 (01) : 253 - 266
  • [49] Glycyrrhizic Acid Alleviates Lipopolysaccharide (LPS)-Induced Acute Lung Injury by Regulating Angiotensin-Converting Enzyme-2 (ACE2) and Caveolin-1 Signaling Pathway
    Yangye Chen
    Lihua Qu
    Yi Li
    Chao Chen
    Wei He
    Li Shen
    Ran Zhang
    Inflammation, 2022, 45 : 253 - 266
  • [50] Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway
    Zhao, Kai
    Tang, Jie
    Xie, Hong
    Liu, Lin
    Qin, Qin
    Sun, Bo
    Qin, Zheng-hong
    Sheng, Rui
    Zhu, Jiang
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
12345